EV/EBITDA:
-5.690.00(0.00%)Summary
- As of today, SPRY EV/EBITDA is -5.69, unchanged during the most recent trading session on November 19, 2025.
- Over the past year, SPRY EV/EBITDA has increased by +13.10 (+69.72%).
- SPRY EV/EBITDA is now -343.16% below its all-time high of 2.34.
Performance
SPRY EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SPRY EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | 0.0% | +0.1% | +0.1% |
| 1M1 Month | +36.4% | -36.4% | -29.4% |
| 3M3 Months | +70.3% | -54.6% | -48.6% |
| 6M6 Months | +86.5% | -54.6% | -50.3% |
| YTDYTD | +97.7% | -29.1% | -32.8% |
| 1Y1 Year | +69.7% | -55.1% | -48.6% |
| 5Y5 Years | - | - | - |
SPRY EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -5.69 | at high | -8.95 | +36.4% |
| 3M | 3-Month | -5.69 | at high | -21.01 | +72.9% |
| 6M | 6-Month | -5.69 | at high | -56.86 | +90.0% |
| 1Y | 1-Year | -5.69 | at high | -397.77 | +98.6% |
| 3Y | 3-Year | -0.59 | -864.4% | -397.77 | +98.6% |
| 5Y | 5-Year | 2.34 | -343.2% | -397.77 | +98.6% |
| All-Time | All-Time | 2.34 | -343.2% | -397.77 | +98.6% |
SPRY EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -5.69(+97.7%) |
| 2024 | -250.24(-5523.4%) |
| 2023 | -4.45(+64.1%) |
| Date | Value |
|---|---|
| 2022 | -12.40(-7850.0%) |
| 2021 | 0.16(+100.3%) |
| 2020 | -52.07 |
FAQ
- What is ARS Pharmaceuticals, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for ARS Pharmaceuticals, Inc.?
- What is SPRY EV/EBITDA year-to-date change?
- What is ARS Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is ARS Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of SPRY is -5.69
What is the all-time high EV/EBITDA for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high EV/EBITDA is 2.34
What is SPRY EV/EBITDA year-to-date change?
ARS Pharmaceuticals, Inc. EV/EBITDA has changed by +244.55 (+97.73%) since the beginning of the year
What is ARS Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, SPRY EV/EBITDA has changed by +13.10 (+69.72%)